A Trial to Investigate the Safety and Pharmacokinetics of GRT6019 in Healthy Male Participants

NCT07347548 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Duchenne Muscular Dystrophy (DMD)

Interventions

DRUG: GRT6019

Sponsor

Grünenthal GmbH